Filing Details
- Accession Number:
- 0000899243-21-033561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-18 19:38:58
- Reporting Period:
- 2021-08-16
- Accepted Time:
- 2021-08-18 19:38:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640322 | L Robert Nussbaum | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-16 | 21,231 | $25.42 | 246,050 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
- Includes an aggregate of 84,134 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- In addition to the transaction being reported, the total amount of securities is 402 shares greater than the reporting person's prior report, which reflects (a) the sale of an additional 66 shares on February 13, 2017, which number of shares subject to the sale was incorrectly reported in a Form 4 filed on February 15, 2017, (b) the sale of an additional 1,198 shares on May 15, 2018, which number of shares subject to the sale was incorrectly reported in a Form 4 filed on May 16, 2018 and (c) an unreported exercise of options for 1,666 shares of common stock, which occurred on January 3, 2017.
Billionaire Hedge Funds
